Optimisation of a novel series of potent and orally bioavailable azanaphthyridine SYK inhibitors

Autor: Garton, Neil S., Barker, Michael D., Davis, Rob P., Douault, Clement, Hooper-Greenhill, Edward, Jones, Emma, Lewis, Huw D., Liddle, John, Lugo, Dave, McCleary, Scott, Preston, Alex G.S., Ramirez-Molina, Cesar, Neu, Margarete, Shipley, Tracy J., Somers, Don O., Watson, Robert J., Wilson, David M.
Zdroj: In Bioorganic & Medicinal Chemistry Letters 1 October 2016 26(19):4606-4612
Databáze: ScienceDirect